Impact of UGT2B17 gene deletion on the steroid profile of an athlete

The measurement of the testosterone to epitestosterone ratio (T/E ratio) in urine is often used as a marker for testosterone administration in the doping control field. This study examines the frequencies of the different expression forms of the UGT2B17 gene, and assesses their effects on this marke...

Full description

Saved in:
Bibliographic Details
Published inPhysiological reports Vol. 3; no. 12; pp. e12645 - n/a
Main Authors Martín‐Escudero, Pilar, Muñoz‐Guerra, Jesús, Del Prado, Nayade, Galindo Canales, Mercedes, Fuentes Ferrer, Manuel, Vargas, Soledad, Soldevilla, Ana B., Serrano‐Garde, Ester, Miguel‐Tobal, Francisco, Maestro de las Casas, Marisa, Fernandez‐Pérez, Cristina
Format Journal Article
LanguageEnglish
Published United States John Wiley and Sons Inc 01.12.2015
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The measurement of the testosterone to epitestosterone ratio (T/E ratio) in urine is often used as a marker for testosterone administration in the doping control field. This study examines the frequencies of the different expression forms of the UGT2B17 gene, and assesses their effects on this marker in volunteer subjects. The sample for this descriptive study was composed of male and female athletes aged between 16 and 55 years old who practiced different sports disciplines. All participants underwent a sports‐medical physical examination, and subsequently provided 10 urine samples consecutively over a period of 48 h. The dependent variable examined was T/E and the main independent variable was the UGT2B17 gene polymorphism. During 1 year, 1410 urine samples were obtained from 141 athletes. The frequencies of the three genotypes were as follows: wt homozygotes (ins/ins) 48.2% (n = 68), mutant homozygotes (del/del) 12.1% (n = 17), and heterozygotes (ins/del) 39.7% (n = 56). Genotype distributions varied significantly (P < 0.001) according to ethnicity, 80% of Asian subjects being homozygous for the gene deletion (del/del) compared to 6.9% of Caucasian subjects. A multivariate analysis adjusted for genotype, age, sex, and sports discipline revealed that athletes with the del/del polymorphism showed a significantly lower mean T/E than heterozygotes (ins/del). In contrast, homozygous athletes for the gene insertion (ins/ins) showed higher mean T/E ratios than heterozygotes (ins/del). UGT2B17 gene deletion has a strong influence on the T/E ratio in urine, which is the most efficient indicator of testosterone prohormone misuse. Others factors studied seem not to have such an impact. The genotyping of UGT2B17 is an important source of information for understanding steroid profiling in the doping control field; therefore it is suggested that it be included in the Athletes Biological Passport. This article is significant in the area of science, as it is the first study with Spanish athletes. This study includes a genetic study of each athlete in relation to UGT2B17 gene and its influence on the testosterone/epitestosterone ratio. WADA needs to consider the influence of the human race in the steroid profile.
AbstractList The measurement of the testosterone to epitestosterone ratio (T/E ratio) in urine is often used as a marker for testosterone administration in the doping control field. This study examines the frequencies of the different expression forms of the UGT2B17 gene, and assesses their effects on this marker in volunteer subjects. The sample for this descriptive study was composed of male and female athletes aged between 16 and 55 years old who practiced different sports disciplines. All participants underwent a sports-medical physical examination, and subsequently provided 10 urine samples consecutively over a period of 48 h. The dependent variable examined was T/E and the main independent variable was the UGT2B17 gene polymorphism. During 1 year, 1410 urine samples were obtained from 141 athletes. The frequencies of the three genotypes were as follows: wt homozygotes (ins/ins) 48.2% (n = 68), mutant homozygotes (del/del) 12.1% (n = 17), and heterozygotes (ins/del) 39.7% (n = 56). Genotype distributions varied significantly (P < 0.001) according to ethnicity, 80% of Asian subjects being homozygous for the gene deletion (del/del) compared to 6.9% of Caucasian subjects. A multivariate analysis adjusted for genotype, age, sex, and sports discipline revealed that athletes with the del/del polymorphism showed a significantly lower mean T/E than heterozygotes (ins/del). In contrast, homozygous athletes for the gene insertion (ins/ins) showed higher mean T/E ratios than heterozygotes (ins/del). UGT2B17 gene deletion has a strong influence on the T/E ratio in urine, which is the most efficient indicator of testosterone prohormone misuse. Others factors studied seem not to have such an impact. The genotyping of UGT2B17 is an important source of information for understanding steroid profiling in the doping control field; therefore it is suggested that it be included in the Athletes Biological Passport. 1. This article is significant in the area of science, as it is the first study with Spanish athletes. 2. This study includes a genetic study of each athlete in relation to UGT2B17 gene and its influence on the testosterone/epitestosterone ratio. 3. WADA needs to consider the influence of the human race in the steroid profile.
The measurement of the testosterone to epitestosterone ratio (T/E ratio) in urine is often used as a marker for testosterone administration in the doping control field. This study examines the frequencies of the different expression forms of the UGT2B17 gene, and assesses their effects on this marker in volunteer subjects. The sample for this descriptive study was composed of male and female athletes aged between 16 and 55 years old who practiced different sports disciplines. All participants underwent a sports-medical physical examination, and subsequently provided 10 urine samples consecutively over a period of 48 h. The dependent variable examined was T/E and the main independent variable was the UGT2B17 gene polymorphism. During 1 year, 1410 urine samples were obtained from 141 athletes. The frequencies of the three genotypes were as follows: wt homozygotes (ins/ins) 48.2% (n = 68), mutant homozygotes (del/del) 12.1% (n = 17), and heterozygotes (ins/del) 39.7% (n = 56). Genotype distributions varied significantly (P < 0.001) according to ethnicity, 80% of Asian subjects being homozygous for the gene deletion (del/del) compared to 6.9% of Caucasian subjects. A multivariate analysis adjusted for genotype, age, sex, and sports discipline revealed that athletes with the del/del polymorphism showed a significantly lower mean T/E than heterozygotes (ins/del). In contrast, homozygous athletes for the gene insertion (ins/ins) showed higher mean T/E ratios than heterozygotes (ins/del). UGT2B17 gene deletion has a strong influence on the T/E ratio in urine, which is the most efficient indicator of testosterone prohormone misuse. Others factors studied seem not to have such an impact. The genotyping of UGT2B17 is an important source of information for understanding steroid profiling in the doping control field; therefore it is suggested that it be included in the Athletes Biological Passport.The measurement of the testosterone to epitestosterone ratio (T/E ratio) in urine is often used as a marker for testosterone administration in the doping control field. This study examines the frequencies of the different expression forms of the UGT2B17 gene, and assesses their effects on this marker in volunteer subjects. The sample for this descriptive study was composed of male and female athletes aged between 16 and 55 years old who practiced different sports disciplines. All participants underwent a sports-medical physical examination, and subsequently provided 10 urine samples consecutively over a period of 48 h. The dependent variable examined was T/E and the main independent variable was the UGT2B17 gene polymorphism. During 1 year, 1410 urine samples were obtained from 141 athletes. The frequencies of the three genotypes were as follows: wt homozygotes (ins/ins) 48.2% (n = 68), mutant homozygotes (del/del) 12.1% (n = 17), and heterozygotes (ins/del) 39.7% (n = 56). Genotype distributions varied significantly (P < 0.001) according to ethnicity, 80% of Asian subjects being homozygous for the gene deletion (del/del) compared to 6.9% of Caucasian subjects. A multivariate analysis adjusted for genotype, age, sex, and sports discipline revealed that athletes with the del/del polymorphism showed a significantly lower mean T/E than heterozygotes (ins/del). In contrast, homozygous athletes for the gene insertion (ins/ins) showed higher mean T/E ratios than heterozygotes (ins/del). UGT2B17 gene deletion has a strong influence on the T/E ratio in urine, which is the most efficient indicator of testosterone prohormone misuse. Others factors studied seem not to have such an impact. The genotyping of UGT2B17 is an important source of information for understanding steroid profiling in the doping control field; therefore it is suggested that it be included in the Athletes Biological Passport.
The measurement of the testosterone to epitestosterone ratio (T/E ratio) in urine is often used as a marker for testosterone administration in the doping control field. This study examines the frequencies of the different expression forms of the UGT 2B17 gene, and assesses their effects on this marker in volunteer subjects. The sample for this descriptive study was composed of male and female athletes aged between 16 and 55 years old who practiced different sports disciplines. All participants underwent a sports‐medical physical examination, and subsequently provided 10 urine samples consecutively over a period of 48 h. The dependent variable examined was T/E and the main independent variable was the UGT 2B17 gene polymorphism. During 1 year, 1410 urine samples were obtained from 141 athletes. The frequencies of the three genotypes were as follows: wt homozygotes ( ins/ins ) 48.2% ( n  = 68), mutant homozygotes ( del/del ) 12.1% ( n  = 17), and heterozygotes ( ins/del ) 39.7% ( n  = 56). Genotype distributions varied significantly ( P  < 0.001) according to ethnicity, 80% of Asian subjects being homozygous for the gene deletion ( del/del ) compared to 6.9% of Caucasian subjects. A multivariate analysis adjusted for genotype, age, sex, and sports discipline revealed that athletes with the del/del polymorphism showed a significantly lower mean T/E than heterozygotes ( ins/del ). In contrast, homozygous athletes for the gene insertion ( ins/ins) showed higher mean T/E ratios than heterozygotes ( ins/del ). UGT 2B17 gene deletion has a strong influence on the T/E ratio in urine, which is the most efficient indicator of testosterone prohormone misuse. Others factors studied seem not to have such an impact. The genotyping of UGT 2B17 is an important source of information for understanding steroid profiling in the doping control field; therefore it is suggested that it be included in the Athletes Biological Passport.
The measurement of the testosterone to epitestosterone ratio (T/E ratio) in urine is often used as a marker for testosterone administration in the doping control field. This study examines the frequencies of the different expression forms of the UGT2B17 gene, and assesses their effects on this marker in volunteer subjects. The sample for this descriptive study was composed of male and female athletes aged between 16 and 55 years old who practiced different sports disciplines. All participants underwent a sports‐medical physical examination, and subsequently provided 10 urine samples consecutively over a period of 48 h. The dependent variable examined was T/E and the main independent variable was the UGT2B17 gene polymorphism. During 1 year, 1410 urine samples were obtained from 141 athletes. The frequencies of the three genotypes were as follows: wt homozygotes (ins/ins) 48.2% (n = 68), mutant homozygotes (del/del) 12.1% (n = 17), and heterozygotes (ins/del) 39.7% (n = 56). Genotype distributions varied significantly (P < 0.001) according to ethnicity, 80% of Asian subjects being homozygous for the gene deletion (del/del) compared to 6.9% of Caucasian subjects. A multivariate analysis adjusted for genotype, age, sex, and sports discipline revealed that athletes with the del/del polymorphism showed a significantly lower mean T/E than heterozygotes (ins/del). In contrast, homozygous athletes for the gene insertion (ins/ins) showed higher mean T/E ratios than heterozygotes (ins/del). UGT2B17 gene deletion has a strong influence on the T/E ratio in urine, which is the most efficient indicator of testosterone prohormone misuse. Others factors studied seem not to have such an impact. The genotyping of UGT2B17 is an important source of information for understanding steroid profiling in the doping control field; therefore it is suggested that it be included in the Athletes Biological Passport. This article is significant in the area of science, as it is the first study with Spanish athletes. This study includes a genetic study of each athlete in relation to UGT2B17 gene and its influence on the testosterone/epitestosterone ratio. WADA needs to consider the influence of the human race in the steroid profile.
The measurement of the testosterone to epitestosterone ratio (T/E ratio) in urine is often used as a marker for testosterone administration in the doping control field. This study examines the frequencies of the different expression forms of the UGT2B17 gene, and assesses their effects on this marker in volunteer subjects. The sample for this descriptive study was composed of male and female athletes aged between 16 and 55 years old who practiced different sports disciplines. All participants underwent a sports-medical physical examination, and subsequently provided 10 urine samples consecutively over a period of 48 h. The dependent variable examined was T/E and the main independent variable was the UGT2B17 gene polymorphism. During 1 year, 1410 urine samples were obtained from 141 athletes. The frequencies of the three genotypes were as follows: wt homozygotes (ins/ins) 48.2% (n = 68), mutant homozygotes (del/del) 12.1% (n = 17), and heterozygotes (ins/del) 39.7% (n = 56). Genotype distributions varied significantly (P < 0.001) according to ethnicity, 80% of Asian subjects being homozygous for the gene deletion (del/del) compared to 6.9% of Caucasian subjects. A multivariate analysis adjusted for genotype, age, sex, and sports discipline revealed that athletes with the del/del polymorphism showed a significantly lower mean T/E than heterozygotes (ins/del). In contrast, homozygous athletes for the gene insertion (ins/ins) showed higher mean T/E ratios than heterozygotes (ins/del). UGT2B17 gene deletion has a strong influence on the T/E ratio in urine, which is the most efficient indicator of testosterone prohormone misuse. Others factors studied seem not to have such an impact. The genotyping of UGT2B17 is an important source of information for understanding steroid profiling in the doping control field; therefore it is suggested that it be included in the Athletes Biological Passport.
Author Muñoz‐Guerra, Jesús
Serrano‐Garde, Ester
Soldevilla, Ana B.
Maestro de las Casas, Marisa
Martín‐Escudero, Pilar
Galindo Canales, Mercedes
Fernandez‐Pérez, Cristina
Fuentes Ferrer, Manuel
Vargas, Soledad
Miguel‐Tobal, Francisco
Del Prado, Nayade
AuthorAffiliation 5 Institute of Healthcare Research of the Hospital Clínico San Carlos (IdISSC) Madrid Spain
3 Unit of Clinical Management (UGC) Department of Preventive Medicine Hospital Clínico San Carlos Madrid Spain
4 Unit of Genomics of the Hospital Clínico San Carlos Madrid Spain
1 Madrid School of Sports Medicine Faculty of Medicine Universidad Complutense de Madrid Madrid Spain
2 Doping Control Laboratory of Madrid and Anti‐doping State Agency Madrid Spain
AuthorAffiliation_xml – name: 2 Doping Control Laboratory of Madrid and Anti‐doping State Agency Madrid Spain
– name: 5 Institute of Healthcare Research of the Hospital Clínico San Carlos (IdISSC) Madrid Spain
– name: 1 Madrid School of Sports Medicine Faculty of Medicine Universidad Complutense de Madrid Madrid Spain
– name: 3 Unit of Clinical Management (UGC) Department of Preventive Medicine Hospital Clínico San Carlos Madrid Spain
– name: 4 Unit of Genomics of the Hospital Clínico San Carlos Madrid Spain
Author_xml – sequence: 1
  givenname: Pilar
  surname: Martín‐Escudero
  fullname: Martín‐Escudero, Pilar
  organization: Institute of Healthcare Research of the Hospital Clínico San Carlos (IdISSC)
– sequence: 2
  givenname: Jesús
  surname: Muñoz‐Guerra
  fullname: Muñoz‐Guerra, Jesús
  organization: Doping Control Laboratory of Madrid and Anti‐doping State Agency
– sequence: 3
  givenname: Nayade
  surname: Del Prado
  fullname: Del Prado, Nayade
  organization: Institute of Healthcare Research of the Hospital Clínico San Carlos (IdISSC)
– sequence: 4
  givenname: Mercedes
  surname: Galindo Canales
  fullname: Galindo Canales, Mercedes
  organization: Institute of Healthcare Research of the Hospital Clínico San Carlos (IdISSC)
– sequence: 5
  givenname: Manuel
  surname: Fuentes Ferrer
  fullname: Fuentes Ferrer, Manuel
  organization: Institute of Healthcare Research of the Hospital Clínico San Carlos (IdISSC)
– sequence: 6
  givenname: Soledad
  surname: Vargas
  fullname: Vargas, Soledad
  organization: Doping Control Laboratory of Madrid and Anti‐doping State Agency
– sequence: 7
  givenname: Ana B.
  surname: Soldevilla
  fullname: Soldevilla, Ana B.
  organization: Doping Control Laboratory of Madrid and Anti‐doping State Agency
– sequence: 8
  givenname: Ester
  surname: Serrano‐Garde
  fullname: Serrano‐Garde, Ester
  organization: Doping Control Laboratory of Madrid and Anti‐doping State Agency
– sequence: 9
  givenname: Francisco
  surname: Miguel‐Tobal
  fullname: Miguel‐Tobal, Francisco
  organization: Institute of Healthcare Research of the Hospital Clínico San Carlos (IdISSC)
– sequence: 10
  givenname: Marisa
  surname: Maestro de las Casas
  fullname: Maestro de las Casas, Marisa
  organization: Institute of Healthcare Research of the Hospital Clínico San Carlos (IdISSC)
– sequence: 11
  givenname: Cristina
  surname: Fernandez‐Pérez
  fullname: Fernandez‐Pérez, Cristina
  organization: Institute of Healthcare Research of the Hospital Clínico San Carlos (IdISSC)
BackLink https://www.ncbi.nlm.nih.gov/pubmed/26668303$$D View this record in MEDLINE/PubMed
BookMark eNqFkUtLAzEURoMoPqor9zJLQap5TZLZCFq1CoIuFHQV0uTGRqaTcTJV-u-dWhUVVAgkkPN93ORsoOUqVoDQNsH7hCvCD-rxjO4TKni-hNYpzklfEXm3_OW8hrZSesQYE8xYgfkqWqNCCMUwW0cnF5Pa2DaLPrsd3tBjIrMHqCBzUEIbYpV1qx1DllpoYnBZ3UQfSpjzpspMO-4w2EQr3pQJtt73Hro9O70ZnPcvr4YXg6PLvuUqz_vGCnCeMmUsU1ZJKT0rLCsKV1BQ3lrurXNGjCizwnLqFPWMez5ySimmRqyHDhe99XQ0AWehahtT6roJE9PMdDRBf7-pwlg_xGfNpcCc5V3B7ntBE5-mkFo9CclCWZoK4jRpogrJhFKc_49KXgiKGZEduvN1rM95Pn65A_YWgG1iSg34T4Rg_aZRzzXqN40dTX7QNrRmLqN7Uyh_ydBF5qWTM_urXl-f39NF6BUs6a76
CitedBy_id crossref_primary_10_1002_dta_2361
crossref_primary_10_1002_dta_2341
crossref_primary_10_1002_dta_3168
crossref_primary_10_1002_dta_3202
crossref_primary_10_1124_dmd_122_001041
crossref_primary_10_1016_j_coemr_2019_05_006
crossref_primary_10_1016_j_steroids_2018_11_009
crossref_primary_10_1111_cts_12569
crossref_primary_10_1016_j_jsbmb_2018_02_013
crossref_primary_10_1016_j_jchromb_2017_03_016
crossref_primary_10_2478_aiht_2024_75_3793
crossref_primary_10_3390_chemosensors9040062
crossref_primary_10_1016_j_chroma_2020_461231
Cites_doi 10.1210/jc.2005-1643
10.1210/jc.2008-1984
10.1210/jc.2011-0521
10.1136/bjsm.2008.056242
10.1373/clinchem.2011.162271
10.1210/jc.2008-0218
10.1016/j.steroids.2008.11.003
10.1111/eci.12037
10.1002/dta.227
10.1093/biostatistics/kxl009
10.1210/jc.2007-0359
10.1016/j.steroids.2010.06.013
10.1016/j.cdp.2007.07.005
ContentType Journal Article
Copyright 2015 The Authors. published by Wiley Periodicals, Inc. on behalf of the American Physiological Society and The Physiological Society.
2015 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of the American Physiological Society and The Physiological Society.
Copyright_xml – notice: 2015 The Authors. published by Wiley Periodicals, Inc. on behalf of the American Physiological Society and The Physiological Society.
– notice: 2015 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of the American Physiological Society and The Physiological Society.
DBID 24P
AAYXX
CITATION
NPM
7X8
7TS
5PM
DOI 10.14814/phy2.12645
DatabaseName Wiley Online Library Open Access
CrossRef
PubMed
MEDLINE - Academic
Physical Education Index
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
Physical Education Index
DatabaseTitleList Physical Education Index
MEDLINE - Academic


PubMed
Database_xml – sequence: 1
  dbid: 24P
  name: Wiley Online Library Open Access
  url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
DocumentTitleAlternate P. Martín‐Escudero et al
EISSN 2051-817X
EndPage n/a
ExternalDocumentID PMC4760435
26668303
10_14814_phy2_12645
PHY212645
Genre article
Journal Article
GrantInformation_xml – fundername: Spanish Ministry of Science and Innovation
  funderid: DEP2009‐14788‐C03‐01/02/03
– fundername: Spanish Ministry of Science and Innovation
  grantid: DEP2009‐14788‐C03‐01/02/03
GroupedDBID 0R~
1OC
24P
53G
5VS
7X7
8-1
8FE
8FH
8FI
8FJ
AAFWJ
AAHHS
AAZKR
ABDBF
ABUWG
ACCFJ
ACCMX
ACUHS
ACXQS
ADBBV
ADKYN
ADRAZ
ADZMN
AEEZP
AEQDE
AFKRA
AIWBW
AJBDE
ALAGY
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AOIJS
AVUZU
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
BVXVI
CCPQU
DIK
EBS
EJD
FYUFA
GODZA
GROUPED_DOAJ
HCIFZ
HMCUK
HYE
IAO
IHR
INH
ITC
KQ8
LK8
M48
M7P
M~E
OK1
PIMPY
PQQKQ
PROAC
RAP
RHI
RPM
UKHRP
WIN
AAYXX
AFPKN
CITATION
PHGZM
PHGZT
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
NPM
PQGLB
7X8
7TS
5PM
ID FETCH-LOGICAL-c4855-ac6edf238ac38c8777f39c399d92e8fcc4fcdda6b23c6c42d82f34f4bd88838b3
IEDL.DBID M48
ISSN 2051-817X
IngestDate Thu Aug 21 18:12:47 EDT 2025
Fri Jul 11 09:47:12 EDT 2025
Wed Jul 30 11:01:26 EDT 2025
Mon Jul 21 05:43:22 EDT 2025
Thu Apr 24 22:59:17 EDT 2025
Tue Jul 01 04:33:04 EDT 2025
Wed Jan 22 16:40:46 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 12
Keywords steroid profile
doping
Exercise
UGT2B17 genotype
Language English
License Attribution
http://creativecommons.org/licenses/by/4.0
http://doi.wiley.com/10.1002/tdm_license_1.1
2015 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of the American Physiological Society and The Physiological Society.
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4855-ac6edf238ac38c8777f39c399d92e8fcc4fcdda6b23c6c42d82f34f4bd88838b3
Notes This study was funded by grants awarded by the Spanish Ministry of Science and Innovation (DEP2009‐14788‐C03‐01/02/03 ‐subprogram DEPO) for competitive investigation in 2009.
Funding Information
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.14814/phy2.12645
PMID 26668303
PQID 1749620317
PQPubID 23479
PageCount 7
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_4760435
proquest_miscellaneous_1897368844
proquest_miscellaneous_1749620317
pubmed_primary_26668303
crossref_primary_10_14814_phy2_12645
crossref_citationtrail_10_14814_phy2_12645
wiley_primary_10_14814_phy2_12645_PHY212645
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate December 2015
PublicationDateYYYYMMDD 2015-12-01
PublicationDate_xml – month: 12
  year: 2015
  text: December 2015
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Hoboken
PublicationTitle Physiological reports
PublicationTitleAlternate Physiol Rep
PublicationYear 2015
Publisher John Wiley and Sons Inc
Publisher_xml – name: John Wiley and Sons Inc
References 2006; 91
2010; 75
2009; 74
2009; 43
2013; 43
2009; 94
2007; 8
2011; 96
2007a; 31
2007; 92
2011; 57
2007; 5
1993
2010; 2
2008; 93
Baron (10.14814/phy2.12645-BIB0001|phy212645-cit-0001) 2007; 5
Donike (10.14814/phy2.12645-BIB0002|phy212645-cit-0002) 1993
Strahm (10.14814/phy2.12645-BIB0016|phy212645-cit-0016) 2009; 43
Strahm (10.14814/phy2.12645-BIB0015|phy212645-cit-0015) 2007; 92
Jakobsson (10.14814/phy2.12645-BIB0007|phy212645-cit-0007) 2006; 91
Sottas (10.14814/phy2.12645-BIB0014|phy212645-cit-0014) 2011; 57
Renterghem (10.14814/phy2.12645-BIB0017|phy212645-cit-0017) 2010; 75
Schulze (10.14814/phy2.12645-BIB0010|phy212645-cit-0010) 2008; 93
Sottas (10.14814/phy2.12645-BIB0013|phy212645-cit-0013) 2007; 8
Ekström (10.14814/phy2.12645-BIB0003|phy212645-cit-0003) 2013; 43
Schulze (10.14814/phy2.12645-BIB0012|phy212645-cit-0012) 2011; 96
Juul (10.14814/phy2.12645-BIB0008|phy212645-cit-0008) 2009; 94
Schulze (10.14814/phy2.12645-BIB0011|phy212645-cit-0011) 2009; 74
10.14814/phy2.12645-BIB0009|phy212645-cit-0009
Fabregat (10.14814/phy2.12645-BIB0004|phy212645-cit-0004) 2010; 2
Gallagher (10.14814/phy2.12645-BIB0005|phy212645-cit-0005) 2007a; 31
References_xml – volume: 2
  start-page: 630
  year: 2010
  end-page: 636
  article-title: Quantification of testosterone and metabolites released after alkaline treatment in human urine
  publication-title: Drug Test Anal.
– volume: 5
  start-page: 118
  year: 2007
  end-page: 123
  article-title: Doping in sport and its spread to populations at risk: an international review
  publication-title: World Psychiatry (Ed Esp)
– volume: 57
  start-page: 969
  year: 2011
  end-page: 976
  article-title: The athlete biological passport
  publication-title: Clin. Chem.
– volume: 94
  start-page: 1005
  year: 2009
  end-page: 1011
  article-title: A common deletion in the Uridine Diphosphate Glucuronyltransferase (UGT) 2B17 gene is a strong determinant of androgen excretion in healthy pubertal boys
  publication-title: J. Clin. Endocrinol. Metab.
– volume: 43
  start-page: 248
  year: 2013
  end-page: 255
  article-title: Testosterone challenge and androgen receptor activity in relation to UGT2B17 genotypes
  publication-title: Eur. J. Clin. Invest.
– volume: 43
  start-page: 1126
  year: 2009
  end-page: 1130
  article-title: Steroid profiles of professional soccer players: an international comparative study
  publication-title: Br. J. Sports Med.
– volume: 31
  start-page: 310
  year: 2007a
  end-page: 315
  article-title: The UGT2B17 gene deletion polymorphism and risk of prostate cancer. A case‐control study in Caucasians
  publication-title: Cancer Detect. Prev.
– volume: 96
  start-page: 1
  year: 2011
  end-page: 8
  article-title: Androgen sulfation in healthy UDP‐glucuronosyl transferase 2B17 enzyme‐deficient men
  publication-title: J. Clin. Endocrinol. Metab.
– volume: 91
  start-page: 687
  year: 2006
  end-page: 693
  article-title: Large differences in testosterone excretion in Korean and Swedish men are strongly associated with a UDP‐glucuronosyl transferase 2B17 polymorphism
  publication-title: J. Clin. Endocrinol. Metab.
– volume: 75
  start-page: 1047
  year: 2010
  end-page: 1057
  article-title: Population based evaluation of a multi‐parametric steroid profiling on administered endogenous steroids in single low dose
  publication-title: Steroids
– volume: 92
  start-page: 4878
  year: 2007
  end-page: 4882
  article-title: The uridine diphosphate glucuronosyltransferase 2B15 D85Y and 2B17 deletion polymorphisms predict the glucuronidation pattern of androgens and fat mass in men
  publication-title: J. Clin. Endocrinol. Metab.
– volume: 8
  start-page: 285
  year: 2007
  end-page: 296
  article-title: Bayesian detection of abnormal values in longitudinal biomarkers with an application to T/E ratio
  publication-title: Biostatistics
– volume: 93
  start-page: 2500
  year: 2008
  end-page: 2506
  article-title: Doping test results dependent on genotype of UGT2B17, the major enzyme for testosterone glucuronidation
  publication-title: J. Clin. Endocrinol. Metab.
– volume: 74
  start-page: 365
  year: 2009
  end-page: 368
  article-title: Substantial advantage of a combined Bayesian and genotyping approach in testosterone doping tests
  publication-title: Steroids
– start-page: 69
  year: 1993
  end-page: 86
– volume: 91
  start-page: 687
  year: 2006
  ident: 10.14814/phy2.12645-BIB0007|phy212645-cit-0007
  article-title: Large differences in testosterone excretion in Korean and Swedish men are strongly associated with a UDP-glucuronosyl transferase 2B17 polymorphism
  publication-title: J. Clin. Endocrinol. Metab.
  doi: 10.1210/jc.2005-1643
– volume: 94
  start-page: 1005
  year: 2009
  ident: 10.14814/phy2.12645-BIB0008|phy212645-cit-0008
  article-title: A common deletion in the Uridine Diphosphate Glucuronyltransferase (UGT) 2B17 gene is a strong determinant of androgen excretion in healthy pubertal boys
  publication-title: J. Clin. Endocrinol. Metab.
  doi: 10.1210/jc.2008-1984
– volume: 5
  start-page: 118
  year: 2007
  ident: 10.14814/phy2.12645-BIB0001|phy212645-cit-0001
  article-title: Doping in sport and its spread to populations at risk: an international review
  publication-title: World Psychiatry (Ed Esp)
– volume: 96
  start-page: 1
  year: 2011
  ident: 10.14814/phy2.12645-BIB0012|phy212645-cit-0012
  article-title: Androgen sulfation in healthy UDP-glucuronosyl transferase 2B17 enzyme-deficient men
  publication-title: J. Clin. Endocrinol. Metab.
  doi: 10.1210/jc.2011-0521
– volume: 43
  start-page: 1126
  year: 2009
  ident: 10.14814/phy2.12645-BIB0016|phy212645-cit-0016
  article-title: Steroid profiles of professional soccer players: an international comparative study
  publication-title: Br. J. Sports Med.
  doi: 10.1136/bjsm.2008.056242
– volume: 57
  start-page: 969
  year: 2011
  ident: 10.14814/phy2.12645-BIB0014|phy212645-cit-0014
  article-title: The athlete biological passport
  publication-title: Clin. Chem.
  doi: 10.1373/clinchem.2011.162271
– volume: 93
  start-page: 2500
  year: 2008
  ident: 10.14814/phy2.12645-BIB0010|phy212645-cit-0010
  article-title: Doping test results dependent on genotype of UGT2B17, the major enzyme for testosterone glucuronidation
  publication-title: J. Clin. Endocrinol. Metab.
  doi: 10.1210/jc.2008-0218
– start-page: 69
  volume-title: Proceedings of the 10th Cologne Workshop on Dope Analysis
  year: 1993
  ident: 10.14814/phy2.12645-BIB0002|phy212645-cit-0002
– volume: 74
  start-page: 365
  year: 2009
  ident: 10.14814/phy2.12645-BIB0011|phy212645-cit-0011
  article-title: Substantial advantage of a combined Bayesian and genotyping approach in testosterone doping tests
  publication-title: Steroids
  doi: 10.1016/j.steroids.2008.11.003
– volume: 43
  start-page: 248
  year: 2013
  ident: 10.14814/phy2.12645-BIB0003|phy212645-cit-0003
  article-title: Testosterone challenge and androgen receptor activity in relation to UGT2B17 genotypes
  publication-title: Eur. J. Clin. Invest.
  doi: 10.1111/eci.12037
– ident: 10.14814/phy2.12645-BIB0009|phy212645-cit-0009
– volume: 2
  start-page: 630
  year: 2010
  ident: 10.14814/phy2.12645-BIB0004|phy212645-cit-0004
  article-title: Quantification of testosterone and metabolites released after alkaline treatment in human urine
  publication-title: Drug Test Anal.
  doi: 10.1002/dta.227
– volume: 8
  start-page: 285
  year: 2007
  ident: 10.14814/phy2.12645-BIB0013|phy212645-cit-0013
  article-title: Bayesian detection of abnormal values in longitudinal biomarkers with an application to T/E ratio
  publication-title: Biostatistics
  doi: 10.1093/biostatistics/kxl009
– volume: 92
  start-page: 4878
  year: 2007
  ident: 10.14814/phy2.12645-BIB0015|phy212645-cit-0015
  article-title: The uridine diphosphate glucuronosyltransferase 2B15 D85Y and 2B17 deletion polymorphisms predict the glucuronidation pattern of androgens and fat mass in men
  publication-title: J. Clin. Endocrinol. Metab.
  doi: 10.1210/jc.2007-0359
– volume: 75
  start-page: 1047
  year: 2010
  ident: 10.14814/phy2.12645-BIB0017|phy212645-cit-0017
  article-title: Population based evaluation of a multi-parametric steroid profiling on administered endogenous steroids in single low dose
  publication-title: Steroids
  doi: 10.1016/j.steroids.2010.06.013
– volume: 31
  start-page: 310
  year: 2007a
  ident: 10.14814/phy2.12645-BIB0005|phy212645-cit-0005
  article-title: The UGT2B17 gene deletion polymorphism and risk of prostate cancer. A case-control study in Caucasians
  publication-title: Cancer Detect. Prev.
  doi: 10.1016/j.cdp.2007.07.005
SSID ssj0001033904
Score 2.0754263
Snippet The measurement of the testosterone to epitestosterone ratio (T/E ratio) in urine is often used as a marker for testosterone administration in the doping...
SourceID pubmedcentral
proquest
pubmed
crossref
wiley
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage e12645
SubjectTerms doping
Exercise
Original Research
steroid profile
UGT2B17 genotype
SummonAdditionalLinks – databaseName: Wiley Online Library Open Access
  dbid: 24P
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3da9RAEB9sffGlqNUav1ih-KBEc5v9fGyr9SxU-tCD8ynsbnZpoc2JXh_63zuzyV09rhwICQQyIWFmd-c3m5nfAOybStmR9bKsUuSlSKoqLfdtqV1yXntZ-cxTcPpDjSfiZCqnQ24O1cL0_BDLDTeaGXm9pgnufN-FRJiRoNa0F7f80wgdutyCh1RcS9T5XJzdbbFUNUb0YqjKo6c-3z2z6ofWwOV6juS_2DU7n-PHsDOgRnbQm_kJPIjdU9g96DBivr5l71nO48wb5Lvw5XsufGSzxCbfzvnhSDMcJJFRxxuyAsMDUR8jhoTZZcuGrt0k7zqWkyvm8RlMjr-eH43LoVdCGYjepXRBxTah_3WhNoFI_lJtA6KP1vJoUggihbZ1yvM6qCB4a3iqRRK-xRC4Nr5-DtvdrIsvgFVSOi0jQjGvEV55K6XGk1ulnZXGFPBhobkmDETi1M_iqqGAgtTckJqbrOYC9pfCv3r-jPvF3i1M0OD4pp8Wrouzmz8NRkxWcVx69AYZY3WtjBGigL3ebMuXIQBRBv10AXrFoEsB4tdevdNdXmSebaFVhWiygI_Z9Ju-vzkb_-T56uV_Sb-CR4jAZJ8f8xq2579v4htEOXP_No_lv4zT95s
  priority: 102
  providerName: Wiley-Blackwell
Title Impact of UGT2B17 gene deletion on the steroid profile of an athlete
URI https://onlinelibrary.wiley.com/doi/abs/10.14814%2Fphy2.12645
https://www.ncbi.nlm.nih.gov/pubmed/26668303
https://www.proquest.com/docview/1749620317
https://www.proquest.com/docview/1897368844
https://pubmed.ncbi.nlm.nih.gov/PMC4760435
Volume 3
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9RAEB_68eKLqPUjfhwrFB-U1GS_90Gk1dZTaDmkB-dT2N3sYqHmtL2C_e-d3UsOa2shCYFMyDKzm_nN7uxvALZ1JU1tnCirGGjJo6xKQ11bKhutU05ULvMUHB7J8ZR_mYnZGgzFOHsFnt8Y2qV6UtOz053fvy7f44B_lwY81zV_iw2iOzW6drEOm-iSVBqhhz3Oz5MtFcPYPq0wU-yEpa7VrN-r98_7iRsYAb1mQxGtwVFdQ5_Xkyj_BrfZOx3cg7s9rCS7y35wH9ZC9wC2djsMqX9cklckJ3rmGfQt-Pg574wk80imn47pXq0I9qJAUkmcZCaCB8JCkigU5ict6ct6J3nbkZx9sQgPYXqwf_xhXPbFFEqf-F9K62VoIzpo65n2iQUwMuMRnrSGBh2959G3rZWOMi89p62mkfHIXYsxMtOOPYKNbt6FJ0AqIawSAbGaU4i_nBFC4UmNVNYIrQt4PWiu8T3TeCp4cdqkiCNpvEkab7LGC9heCf9cEmzcLPZyMEGDAyCtatguzC_OGwypjKT4b1K3yGijmNSa8wIeL822-thg7wLUFYOuBBIB99Un3cn3TMTNlawQbhbwJpv-tvY3k_E3mu-e_rcFz-AOwjGxTJZ5DhuLs4vwAiHPwo1gnfIJXtVMjWBzb_9o8nWUpw9GuaP_ATMT_qM
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3dT9RAEJ8gPOiLUUGtn2tCeIBUe9v9fEQBDwXCw12CT83udjeQaM_o8cB_78y2HF4wJCZt0qTTtNnZ2fnNdPY3AJumUnZkvSyrFHkpkqpKy31bapec115WPvMUHJ-o8VR8OZNnQ8KN9sL0_BCLhBtZRl6vycApIZ2tXJiRoN6051f8_Qg9urwHa0JxTYbJxelNjqWqMaQXw7Y8eurDzTPLjugWurxdJPk3eM3e5-ARPBxgI9vt9fwYVmL3BNZ3OwyZf1yxLZYLOXOGfB32DvPORzZLbPp5wj-ONMNZEhm1vCE1MDwQ9jGiSJhdtGxo203yrmO5umIeN2B6sD_5NC6HZgllIH6X0gUV24QO2IXaBGL5S7UNCD9ay6NJIYgU2tYpz-ugguCt4akWSfgWY-Da-PoprHazLj4HVknptIyIxbxGfOWtlBpPbpV2VhpTwPb1yDVhYBKnhhbfG4ooaJgbGuYmD3MBmwvhnz2Bxr_F3l2roMEJTn8tXBdnl78bDJms4rj26DtkjNW1MkaIAp71alu8DBGIMuioC9BLCl0IEMH28p3u4jwTbQutKoSTBexk1d_1_c3p-BvPVy_-S_ot3B9Pjo-ao8OTry_hAcIx2RfLvILV-a_L-Bohz9y_yfP6D-up-wc
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3da9RAEF-0BfFFqvUjtdUVig9KbG6zn4-n9bz6UfrQSPUl7CctaK7U60P_-85s0qtHpSAkEMiEhJnZnd9sZn9DyLaupBkZJ8oqRVbyJKvSMBdKZZN1yonKZZ6Cb_ty2vDPR-JoqM3BvTA9P8RiwQ1HRp6vcYCfhpQHOdcjjq1pjy_YuxEEdHGXrCJPHjj16vh787O5XmSpasjp-bAvD5_buX5qORLdgJc3qyT_Rq85_EzWyIMBN9Jxb-iH5E7sHpH1cQc58-8L-prmSs68RL5Odvfy1kc6S7T5dMjejxQFN4kUe96gHSgcgPsociTMTgId-najvO1oLq-Yx8ekmXw8_DAth24JpUeCl9J6GUOCCGx9rT3S_KXaeMAfwbCok_c8-RCsdKz20nMWNEs1T9wFSIJr7eonZKWbdfEZoZUQVokIYMwpAFjOCKHgZEYqa4TWBXlzpbnWD1Ti2NHiV4spBaq5RTW3Wc0F2V4In_YMGv8We3VlghY8HH9b2C7Ozv-0kDMZyWDyUbfIaKNqqTXnBXnam23xMoAgUkOkLohaMuhCABm2l-90J8eZaZsrWQGeLMjbbPrbvr89mP5g-Wrjv6RfknsHu5P2697-l-fkPsAx0RfLbJKV-dl53ALIM3cvBse-BDI9-_8
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Impact+of+UGT2B17+gene+deletion+on+the+steroid+profile+of+an+athlete&rft.jtitle=Physiological+reports&rft.au=Mart%C3%ADn-Escudero%2C+Pilar&rft.au=Mu%C3%B1oz-Guerra%2C+Jes%C3%BAs&rft.au=Del+Prado%2C+Nayade&rft.au=Galindo+Canales%2C+Mercedes&rft.date=2015-12-01&rft.issn=2051-817X&rft.eissn=2051-817X&rft.volume=3&rft.issue=12&rft_id=info:doi/10.14814%2Fphy2.12645&rft_id=info%3Apmid%2F26668303&rft.externalDocID=26668303
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2051-817X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2051-817X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2051-817X&client=summon